158 Results for "

3CL

" in MedChemExpress (MCE) Product Catalog:
Products (158)

158 Results for "3CL" in MCE Product Catalog:

Cat. No.: HY-15298C
CAS No.: 1425038-27-2
Synonyms: MK-5172 sodium salt
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Grazoprevir sodium salt (MK-5172 sodium salt) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir sodium salt inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
Cat. No.: HY-12530S1
Synonyms: GS-5816-d33
Velpatasvir-d3 (GS-5816-d3) is deuterium labeled Velpatasvir. Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM [3].
loading...
    loading...
Cat. No.: HY-162414
CAS No.: 214221-82-6
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-84 (compound 20) is aSARS-CoV-2 inhibitor that targets the 3CL protease (3CL Pro) of SARS-CoV-2 (IC50: 369.5 nM ) .
loading...
    loading...
Cat. No.: HY-133828
CAS No.: 1166-34-3
Target:  

5-HT Receptor SARS-CoV

Research Areas:  

Infection

Cinanserin (SQ 10643) is a potent and selective 5-HT2 antagonist with Ki values of 41, 3500 nM for 5-HT2, 5-HT1, respectively. Cinanserin also is a SARS-CoV 3CL pro inhibitor with an KD value of 49.4, 18.2 µM for SARS-CoV 3CL pro, HCoV-229E 3CL pro, respectively. Cinanserin reduces systemic burn edema levels [3].
loading...
    loading...
Cat. No.: HY-170819
Target:  

SARS-CoV Cathepsin

Research Areas:  

Infection

VK13 (Compound 6) is a potent inhibitor of human cathepsin L (hCatL) with a Ki value of 0.55 nM and SARS-CoV-2 3CL pro (3CL-PR) with a Ki value of 2.6 nM. VK13 exhibits anti-CoV-2 activity with an EC50 of 1.25 μM .
loading...
    loading...
Cat. No.: HY-149655
CAS No.: 2894770-40-0
Target:  

SARS-CoV

Research Areas:  

Infection

D1N8 is a potent SARS-CoV-2 3CL pro inhibitor with an IC50 and CC50 values of 0.44 μM and >20 μM, respectively. D1N8 has the potential for the research of anti-SARS-CoV-2 agents targeting 3CL pro .
loading...
    loading...
Cat. No.: HY-144061
CAS No.: 2735704-19-3
Target:  

SARS-CoV

Research Areas:  

Infection

INSCoV-601I(1) is a potent inhibitor of M pro (3CL pro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-601I(1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) .
loading...
    loading...
Cat. No.: HY-144063
CAS No.: 2735704-15-9
Target:  

SARS-CoV

Research Areas:  

Infection

INSCoV-600K(1) is a potent inhibitor of M pro (3CL pro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-600K(1) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1) .
loading...
    loading...
Cat. No.: HY-144833
CAS No.: 2757970-20-8
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CL pro. 3CL pro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral agents. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases .
loading...
    loading...
Cat. No.: HY-149656
CAS No.: 2894770-48-8
Target:  

SARS-CoV

Research Areas:  

Infection

D1N52 is a potent SARS-CoV-2 3CL pro inhibitor with an IC50 of 0.53 μM .
loading...
    loading...
Cat. No.: HY-139683
CAS No.: 2698336-82-0
Purity:  98.93%
Target:  

SARS-CoV

Research Areas:  

Infection

Antiviral agent 5 is an intermediate used in antiviral agents targeting 3C and 3CL proteases including SARS-CoV-2 M pro.
loading...
    loading...
Cat. No.: HY-169997
Target:  

SARS-CoV

Research Areas:  

Infection

LU9 is a potent 3CL pro inhibitor with an IC50 value of 0.34 µM. LU9 has the potential for the research of SARS-CoV-2 .
loading...
    loading...
Cat. No.: HY-111074
CAS No.: 934017-32-0
Synonyms: MK-0767 analog
Target:  

SARS-CoV

Research Areas:  

Infection Metabolic Disease

DB12055 (MK-0767 analog) is a covalent SARS-CoV-2 3CL protease inhibitor. DB12055 has the potential for the study of dyslipidemia and diabetes mellitus .
loading...
    loading...
Cat. No.: HY-152589
CAS No.: 2761367-25-1
Target:  

SARS-CoV

Research Areas:  

Infection

Antiviral agent 25 (compound 6g) is a new non-peptide analog covalent inhibitor of SARS-CoV-2 3CL pro. Antiviral agent 25 has a strong inhibitory effect on SARS-CoV-2 3CL pro and SARS-CoV-2 PL pro with IC50 values of 0.118 µM, 0.448 µM, respectively. Antiviral agent 25 has antiviral effect on SARS-CoV-2 with an EC50 value of 7.249 µM .
loading...
    loading...
Cat. No.: HY-151535
CAS No.: 2913186-57-7
Target:  

SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

SARS-CoV-2 3CLpro-IN-5 is a covalent inhibitor of 3C-like protease (3CL pro). SARS-CoV-2 3CLpro-IN-5 has inhibitory activity for 3CL pro with an IC50 value of 3.8 nM. SARS-CoV-2 3CLpro-IN-5 has 9.0% oral bioavailability (BA). SARS-CoV-2 3CLpro-IN-5 can be used for the research of coronavirus disease 2019 (COVID-19) .
loading...
    loading...
Cat. No.: HY-150691
CAS No.: 2409178-86-3
Target:  

SARS-CoV

Research Areas:  

Cancer

SARS 3CLpro-IN-1 (Compound 3b) is a SARS 3CL protease inhibitor with an IC50 value of 95 μM, as a specific stereo isomer of the octahydroisochromene scaffold, directs the P1 site imidazole .
loading...
    loading...
Cat. No.: HY-W653853
CAS No.: 1217673-23-8
Synonyms: ABT 538-13C3; RTV-13C3
Ritonavir- 13C3 is 13C labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.61 μM .
loading...
    loading...
Cat. No.: HY-90001S2
Synonyms: ABT 538-d8; RTV-d8
Ritonavir-d8 is deuterated labeled Ritonavir (HY-90001). Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.61 μM.
loading...
    loading...
Cat. No.: HY-146998
CAS No.: 2765088-93-3
Purity:  99.71%
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases .
loading...
    loading...
Cat. No.: HY-168430
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 3CLpro-IN-30 (compound 29) is a potent inhibitor of SARS-CoV-2 3CL protease (SARS-CoV-2 3CLpro), with the IC50 and EC50 of 0.04 and 0.3 μM .
loading...
    loading...